Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests

Journal of Clinical Microbiology

Volumn 38, Issue 3, 2000, Pages 1247-1249

  Jagodzinski, Linda L ^a   Wiggins, Debra L ^a   McManis, Joshua L ^b   Emery, Sandra ^c   Overbaugh, Julie ^c   Robb, Merlin ^b   Bodrug, Sharon ^d   Michael, Nelson L ^b  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Gen Probe Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CALIBRATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RNA ANALYSIS; STANDARD; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034005970     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.3.1247-1249.2000     Document Type: Article

References (28)

1. Alaeus, A., T. Leitner, K. Lidman, and J. Albert. 1997. Most HIV-1 genetic subtypes have entered Sweden. AIDS 11:199-202.
2. Alaeus, A., K. Lidman, A. Sonnerborg, and J. Albert. 1997. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 11:859-865.
3. Bodrug, S., R. Domingo, J. Holloway, M. Sanders, K. Nunomura, C. Sloan, and B. Billyard. 1997. Gen-probe single-tube quantitative HIV assay. J. Clin. Microbiol. Infect. 3:1050.
4. Brambilla, D., S. Leung, J. Lew, J. Todd, S. Herman, M. Cronin, D. E. Shapiro, J. Bremer, C. Hanson, G. V. Hillyer, G. D. McSherry, R. S. Sperling, R. W. Coombs, and F. S. Reichelderfer. 1998. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J. Clin. Microbiol. 36:311-314.
5. Brodine, S. K., R. A. Shaffer, M. J. Starkey, S. A. Tasker, J. L. Gilcrest, M. K. Louder, A. Barile, T. C. VanCott, M. T. Vahey, F. E. McCutchan, D. L. Birx, D. D. Richman, and J. R. Mascola. 1999. Drug resistance patterns, genetic subtypes, clinical features and risk factors in military personnel with HIV-1 seroconversion. Ann. Intern. Med. 131:502-506.
6. Brodine, S. K., J. R. Mascola, P. J. Weiss, S. I. Ito, K. R. Porter, A. W. Artenstein, F. C. Garland, F. E. McCutchan, and D. S. Burke. 1995. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 346:1198-1199.
7. Centers for Disease Control and Prevention. 1998. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infectcd adults and adolescents. Morbid. Mortal. Weekly Rep. 47:1-63.
8. Coste, J., B. Montes, J. Reynes, M. Peeters, C. Segarra, J. P. Vendrell, E. Delaporte, and M. Segondy. 1996. Comparative evaluation ol three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50:293-302.
9. Damond, F., C. Apetrei, D. Descamps, F. Brun-Vezinet, and F. Simon. 1999. HIV-1 subtypes and plasma RNA quantification. AIDS 13:286-288. (Letter.)
10. de Baar, M. P., A. M. van der Schoot, J. Goudsmit, F. Jacobs, R. Ehren, K. H. van der Horn, P. Oudshoorn, F. de Wolf, and A. de Ronde. 1999. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J. Clin. Microbiol. 37:1813-1818.
11. Debyser, Z., E. Van Wijngaerden, K. Van Laethem, K. Beuselinck, M. Reynders, E. De Clercq, J. Desmyter, and A. M. Vandamme. 1998. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res. Hum. Relrovir. 14:453-459.
12. Giachetti, C., D. Kolk, J. Dockter, J. Knowlton, K. Wang, H. Hotaling, and S. McDonough. 1998. High throughput assay for sensitive detection of HIV-1 RNA of diverse subtype origins, including type O strains. Int. Conf. AIDS 12:151-155.
13. Gurtler, L. G., P. H. Hauser, J. Eberle, A. von Brunn, S. Knapp, L. Zekeng, J. M. Tsague, and L. Kaptue. 1994. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68:1581-1585.
14. Hoff, R., and L. F. Barker. 1995. Trial objectives and end points for measuring the efficacy of HIV vaccines. Infect. Dis. Antimicrob. Agents 4:95-101.
15. Korber, B., B. Foley, T. Leitner, F. McCutchan, B. Hahn, J. W. Mellors, G. Myers, and C. Kuiken. 1997. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex.
16. Leitner, T., D. Escanilla, S. Marquina, J. Wahlberg, C. Brostrom, H. B. Hansson, M. Uhlen, and J. Albert. 1995. Biological and molecular characterization of subtype D. G. and A/D recombinant HIV-1 transmissions in Sweden. Virology 209:136-146.
17. Lew, J., P. Reichelderfer, M. Fowler, J. Bremer, R. Carrol, S. Cassol, D. Chernoff, R. Coombs, M. Cronin, R. Dickover, S. Fiscus, S. Herman, B. Jackson, J. Kornegay, A. Kovacs, K. McIntosh, W. Meyer, N. Michael, L. Mofenson, J. Moye, T. Quinn, M. Robb, M. Vahey, B. Weiser, and T. Yeghiazarian for the TUBE Meeting Workshop Attendees. 1998. Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. J. Clin. Microbiol. 36: 1471-1479.
18. McCutchan, F. E., M. O. Salminen, J. K. Carr, and D. S. Burke. 1996. HIV-1 genetic diversity. AIDS 10:S13-S20.
19. Mellors, J. W., L. A. Kingsley, C. J. Rinaldo, J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
20. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
21. Michael, N. L., S. A. Herman, S. Kwok, K. Dreyer, J. Wang, C. Chistopherson, J. P. Spadoro, K. K. Y. Young, V. Polonis, F. E. McCutchan, J. Carr, J. R. Mascola, L. L. Jagodzinski, and M. L. Robb. 1999. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 37: 2557-2563.
22. Nolte, F. S., J. Boysza, C. Thurmond, W. S. Clark, and J. L. Lennox. 1998. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:716-720.
23. O'Brien, W. A., P. M. Hartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, M. S. Simberkoff, J. D. Hamilton and the Veterans Affairs Cooperative Study Group on AIDS. 1996. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS, N. Engl. J. Med. 334:426-431.
24. Parekh, B., S. Phillips, T. C. Granade, J. Baggs, D. J. Hu, and R. Respess. 1999. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res. Hum. Retrovir. 15:133-142.
25. Rida, W., P. Fast, R. Hoff, and T. Fleming. 1997. Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol, 16:195-203.
26. Robertson, D. L., B. Hahn, F. McCutchan, and P. Sharp. 1995. Recombination in HIV-1. Nature 374:124-126.
27. Triques, K., J. Coste, J. L. Perret, C. Segarra, E. Mpoudi, J. Reynes, E. Delaporte, A. Butcher, K. Dreyer, S. Herman, J. Spadoro, and M. Peeters. 1999. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 37:110-116.
28. Vanden Haesevelde, M., J. L. Decourt, R. J. De Leys, B. Vanderborght, G. van der Groen, H. van Heuverswijn, and E. Saman. 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68:1586-1596.